Clinical Trial Update: Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating paclitaxel plus irinotecan (CPT-11) for second-line treatment in patients with inoperable or recurrent gastric cancer has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: WITHDRAWN